Sort by
Refine Your Search
-
for metastatic melanoma, but most patients develop resistance. Because of this, ERKs are important therapeutic targets, and high-affinity inhibitors are in clinical trials. Therefore, understanding the molecular
-
research program focuses on engineering these nanoparticles with desired physical and chemical properties and specified functionality through wet-chemistry synthesis. We are particularly interested in
-
are developing machine learning-driven autonomous metrology research systems, with the goal of accelerating the development of self-correcting photonic and quantum sensor networks. These systems combine machine
-
Description We are using innovative processing to develop novel superconducting materials with enhanced properties for quantum circuit applications. Critical elements for development of these materials
-
, plays an important role at NIST in the development and interpretation of new measurement techniques, as well as aiding the understanding of the behavior of new materials in existing measurements. In
-
301.538.9058 Description Generation, control and detection of optical radiation either spectrally, temporally, or spatially is fundamental to optical technologies. Developing a versatile, manufacturable, and
-
. The postdoc will develop machine learning algorithms to analyze phenotype and sequence data, as well as active learning algorithms to optimize and control experiments in directed evolution. This position
-
@nist.gov 301.975.4127 Description This research is centered on the development and application of analytical methods to the characterization of nanomaterials. Opportunities exist to study the composition
-
various government laboratories to elucidate mechanisms of protein binding to BLMs. We comprise researchers with a broad range of expertise and are actively developing advanced biochemical and biophysical
-
are needed to support the clinical testing community and manufacturers of working standard materials. Challenges lie in developing relevant standards in a timely fashion to support new clinical targets and